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PEthnic Differences in Left Ventricular
Remodeling in Highly-Trained Athletes
Relevance to Differentiating Physiologic Left
Ventricular Hypertrophy From Hypertrophic Cardiomyopathy
Sandeep Basavarajaiah, MBBS, MRCP,*† Araceli Boraita, MD,‡ Gregory Whyte, PHD,§
Mathew Wilson, MSC,† Lorna Carby, BSC,† Ajay Shah, MD, FRCP,*
Sanjay Sharma, BSC (HONS), MD, FRCP*†
London, United Kingdom; and Madrid, Spain
Objectives The purpose of this study was to evaluate ethnic differences in left ventricular (LV) remodeling between highly-
trained athletes of African/Afro-Caribbean (black) and Caucasian (white) athletes.
Background The upper limits of left ventricular hypertrophy (LVH) are established in white athletes and aid the differentiation
of physiologic LVH from hypertrophic cardiomyopathy (HCM). However, there are few data regarding LV remodel-
ing in black athletes, in whom deaths from HCM are more prevalent.
Methods Between 2003 and 2007, 300 nationally ranked black male athletes (mean age 20.5 years) underwent 12-lead
electrocardiogram and 2-dimensional echocardiography. The results were compared with 150 black and white
sedentary individuals and 300 highly-trained white male athletes matched for age, size, and sport.
Results Black athletes exhibited greater LV wall thickness and cavity size compared with sedentary black and white indi-
viduals. Black athletes had greater LV wall thickness compared with white athletes (11.3  1.6 mm vs. 10 
1.5 mm; p  0.001). In absolute terms, 54 black athletes (18%) had LV wall thickness 12 mm compared with
12 white athletes (4%), and 3% of black athletes exhibited LV wall thickness 15 mm compared with none of
the white athletes. Black athletes with LVH displayed an enlarged LV cavity and normal diastolic function.
Conclusions Black athletes develop a greater magnitude of LVH compared with white athletes; therefore, extrapolation of
conclusions derived from white athletes has the potential of generating false-positive diagnoses of HCM in black
athletes. (J Am Coll Cardiol 2008;51:2256–62) © 2008 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.12.061b
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Sarticipation in intensive physical exercise is associated with
ncreased left ventricular (LV) dimensions (1–3). The upper
imits of LV wall thickness are established in Caucasian
white) athletes (1,3) and serve an important role in differ-
ntiating physiologic LV hypertrophy (LVH) from hyper-
rophic cardiomyopathy (HCM) (4). There are few studies
ddressing cardiovascular adaptation in athletes of African/
fro-Caribbean origin (black), in whom deaths attributed
o HCM are more common (5). It is uncertain whether
xtrapolation of conclusions relating to LV wall thickness
easurements derived from white athletes can be applied
ccurately to confirm or refute the presence of HCM in
rom the *King’s College Hospital, London, United Kingdom; †University Hospital
ewisham, London, United Kingdom; ‡Sport Medicine Center, Higher Sports
ouncil, Madrid, Spain; and the §Olympic Medical Institute, London, United
ingdom. Dr. Basavarajaiah received a junior research fellow grant from the
haritable organization Cardiac Risk in the Young.g
Manuscript received October 23, 2007; revised manuscript received December 12,
007, accepted December 17, 2007.lack athletes. However, a study of intercollegiate black
thletes suggested that black athletes are capable of devel-
ping substantial LVH (6), indicating that increases in
re-load and after-load associated with intensive exercise
ay be associated with a greater degree of LVH in black
See page 2263
thletes compared with white athletes. Paucity of data on
ardiovascular adaptation in black athletes has the potential
f generating false-positive diagnoses of HCM and unnec-
ssary disqualification from competitive sport. The present
tudy aimed to evaluate ethnic differences in cardiovascular
daptation to intensive exercise between black and white
thletes.
ethods
etting. The United Kingdom does not have a formal
overnment-sponsored pre-participation screening program
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June 10, 2008:2256–62 LV Remodeling in Black Athletesor athletes; however, some national sporting organizations
und independent cardiovascular screening for recruits be-
ore acceptance for competition. Our organization has been
esponsible for evaluating athletes from the British Lawn
ennis Association, Premiership Soccer and Rugby League,
nd national swimming and rowing squads since 1996. In
003, the program was extended to include basketball,
oxing, and track events to enable assessment of elite black
thletes.
efinitions. The term “black” was used to denote individ-
als of African or Afro-Caribbean descent (7,8). The
thnicity assigned to each black athlete and control relied
urely on information provided on health questionnaires.
The term “elite athlete” was applied to individuals who
nderwent organized training and participated in a team or
ndividual sport at a national level. The term “sedentary”
as ascribed to individuals participating in 2 h of orga-
ized physical activity per week. Based on previous studies
n athletes, “LVH” was defined as an end-diastolic LV wall
hickness 12 mm (1,3).
thletes. Between 2003 and August 2007, 300 asymptom-
tic elite black male athletes underwent 12-lead electrocar-
iogram (ECG) and 2-dimensional echocardiography dur-
ng the peak competitive season. Athletes had a mean age of
0.5  5.8 years (range 14 to 35 years) and a mean body
urface area (BSA) of 1.94  0.16 m2 (range 1.3 to 2.29
2). Athletes were Afro-Caribbean (42%), West African
40%), or East African (18%) in origin. Athletes of East
frican origin had a lower BSA compared with other black
thletes (1.89  0.15 m2 vs. 1.97  0.16 m2; p  0.001).
thletes trained for an average of 14  7 h (range 10 to
6 h) per week, and all had competed at the national level
n the 4-year period. The athletes participated in 6 different
porting disciplines (soccer, n  90 [30%]; boxing, n  60
20%]; basketball, n  55 [18%]; track sprinting, n  21
7%]; long-distance running, n  39 [13%]; rugby, n  29
10%]; and tennis, n  6 [2%]). Written consent for
valuation was obtained from individuals 16 years and
rom a parent/guardian for those 16 years of age.
ontrol subjects. Control subjects comprised 150 black
nd 150 white sedentary males and 300 white male elite
thletes of similar age and BSA as the study subjects.
edentary control subjects were recruited from large second-
ry schools and community centers. Elite white athletes
ere recruited from the same sporting disciplines/clubs that
rovided black athletes for the study and therefore endured
imilar training programs.
Ethical approval for the study was obtained from the
niversity Hospital Lewisham Research Ethics Committee.
lectrocardiography. A standard 12-lead ECG was re-
orded using a Marquette Hellige recorder (Milwaukee,
isconsin) with a paper speed of 25 mm/s and amplifica-
ion of 0.1 mV/mm (9). The Sokolow-Lyon voltage criteria
ere used to identify LVH (10).
chocardiography. Two-dimensional echocardiography
as performed by 2 experienced sonographers using GE mivid I laptop portable (General
lectric, Tirat Carmel, Israel)
nd Philips Sonos 7500 (Philips,
othell, Washington) echocardi-
graphy machines. Images of the
eart were obtained in the stan-
ard views as previously described
11). The LV wall thickness was
easured from 2-dimensional
ong- and short-axis views in end-
iastole at the level of the mitral
alve leaflet tips and the papillary
uscles; the greatest measurement
efined maximal LV wall thick-
ess. M-mode echocardiograms
erived from 2-dimensional im-
ges in the parasternal long axis were used to measure LV
nd-diastolic and -systolic dimensions and the left atrial and
ortic root diameters according to the American Society of
chocardiography (12). Repeat measurements were per-
ormed by a cardiologist blind to the identity of the subjects.
elative wall thickness (h/R), where h is the sum of the
nterventricular septal and posterior wall thickness in end-
iastole (mm) and R is the LV cavity size in end-diastole
mm), was calculated for each athlete. Percentage LV
hortening fraction was calculated as an index of systolic
unction. Pulsed Doppler recordings were performed at the
istal margins of mitral valve leaflets for early (E) and late
A) diastolic velocities (13). Tissue Doppler imaging (TDI)
f septal and lateral mitral annulular movement was ob-
ained from the apical 4-chamber views, as previously
escribed (14), to obtain early (E=) and late (A=) diastolic
eak velocities. The ratio of early to late annular velocity
E=/A=) and the ratio of transmitral flow velocity to annular
elocity (E/E=) were calculated to provide indexes of dia-
tolic function. Left ventricular mass was calculated using
he formula of Devereux (15).
Athletes with LVH underwent upright exercise stress
esting and 48-h Holter monitoring to check for the broader
henotype of HCM.
xercise stress testing. An upright stress test was per-
ormed using the standard Bruce Protocol (16). The ECG
nd blood pressure (BP) were recorded at 1-min intervals.
thletes were exercised to volitional exhaustion and assessed
pecifically for the development of ischemic changes, abnor-
al or flat BP response (17), and tachyarrhythmias.
8-h ECG monitoring. The 48-h ambulatory ECG mon-
toring was performed to check specifically for supraventric-
lar and/or ventricular tachyarrhythmias. Athletes were
ncouraged to continue usual day-to-day life activities,
ncluding exercise, during the investigation.
tatistical analysis. Data are expressed as mean  SD.
tatistical analyses were performed using the unpaired
tudent t test, univariate analysis of variance test with post
oc Bonferroni correction, and chi-square test. A stepwise
Abbreviations
and Acronyms
BP  blood pressure
BSA  body surface area
ECG 
electrocardiography/
electrocardiogram
HCM  hypertrophic
cardiomyopathy
LV  left ventricular
LVH  left ventricular
hypertrophy
TDI  tissue Doppler
imagingultivariate linear model was produced to assess the rela-
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LV Remodeling in Black Athletes June 10, 2008:2256–62ionship between LV wall thickness as a dependent variable
nd weight, height, age, ethnicity, type of sport, and
uration of training as independent variables. A 2-tailed
value of 0.05 was considered to be statistically signifi-
ant. Intraobserver and interobserver reliability for maximal
eft ventricular wall thickness measurements was expressed
s the coefficient of variance (%).
esults
edentary control subjects. Black and white control sub-
ects were of similar age (19.4  6.4 years vs. 20.5  5.8
ears) and BSA (1.89  0.5 m2 vs. 1.82  0.2 m2). There
ere no differences in LV wall thickness or LV cavity
etween black and white sedentary control subjects (9.0 
.2 mm vs. 8.8  1.3 mm and 49  5.2 mm vs. 48  4.0
m, respectively). None of the control subjects exhibited a
V wall thickness 12 mm or LV cavity size 55 mm.
ardiac dimensions in black athletes versus black control
ubjects and white athletes. Black athletes and white
thletes exhibited a greater LV wall thickness, cavity size,
nd left atrial diameter compared with black control sub-
ects. Both black athletes and white athletes displayed
nhanced diastolic LV filling (E= and E/E=) compared with
lack control subjects on TDI (Table 1). Black athletes
emonstrated a greater magnitude of LV wall thickness and
V mass compared with white athletes, amounting to a 12%
nd 13% difference, respectively (Table 1). There were no
ifferences in the LV cavity size, left atrial diameter,
aseline LV function, and BP between black athletes and
hite athletes.
lack athletes with LVH. In absolute terms, 54 black
thletes (18%) had LV wall thickness 12 mm (LVH)
omparison Between Black Athletes, White Athletes, and Black C
Table 1 Comparison Between Black Athletes, White Athletes,
Black Athletes (n  300) White Athlete
Age (yrs) 20.5 5.8 (14–35) 20.2 4.9 (
BSA (m2) 1.93 0.2 1.89 0.3
Systolic BP (mm Hg) 118 7 (80–140) 115 6 (95
LVWTd (mm) 11.3 1.6* (8–16) 10.0 1.5 (
LVIDd (mm) 53 4.4† (44–64) 53.6 4.1 (
LA diam. (mm) 36 4† (20–48) 36 4 (24
h/R 0.42 0.07* 0.36 0.06
LVM (g) 286 78* (113–618) 250 62 (1
E (m/s) 0.87 0.2† (0.5–1.5) 0.89 0.3 (
A (m/s) 0.4 0.2 (0.2–0.7) 0.5 0.3 (
E/A 2.3 0.9 (1.6–4.8) 2.2 1 (1.
E= (m/s) 0.22 0.2† (0.16–0.29) 0.23 0.1 (
A= (m/s) 0.05 0.01† (0.03–0.08) 0.05 0.01
E=/A= 2 0.4† (1.7–4.6) 2 0.5 (
E/E= 4.6 1.3† (3.2–7.5) 4.5 1.4 (
FS 35.2 6.8 (20–51) 36.3 5.7 (
ata expressed as mean standard deviation (range). *More significant compared with black cont
thletes.
A  late mitral valve inflow peak velocity; A=  late annular diastolic peak velocity; ANOVA  a
nflow velocity; E=  early diastolic annular peak velocity; FS  fractional shortening; h/R  relat
nd-diastole; LVM  left ventricular mass; LVWTd  maximal left ventricular wall thickness in endompared with 12 white athletes (4%) (p  0.001). Theaximal LV wall thickness measured in any black athlete
as 16 mm, compared with 14 mm in any white athlete
Fig. 1). Nine black athletes (3%) exhibited substantial LV
all thickness 15 mm (Table 2).
emographics. Black athletes with LVH had a larger BSA
ompared with black athletes without LVH (2.0  0.2 m2
s. 1.92  0.2 m2; p  0.01). There were no differences
etween the 2 groups in relation to age or intensity of
raining, but all black athletes with LVH were age 16
ears. In terms of ancestral origin of black athletes, 50 (20%)
f the 246 athletes of West African ancestry (including
aribbean individuals) exhibited LVH versus 4 (7%) of 54
thletes of East African origin (p  0.01).
l Subjects
lack Control Subjects
300) Black Control Subjects (n  150) p Value (ANOVA)
) 19.4 6.4 (14–35) NS
1.87 0.5 NS
119 12 (85–145) NS
9.0 1.2 (6–12) 0.001
) 49 5.2 (28–55) 0.001
31 4 (23–41) 0.001
0.35 0.06 0.001
9) 225 60 (110–360) 0.001
2) 0.8 0.2 (0.5–1.0) NS
9) 0.5 0.2 (0.3–0.8) NS
1.3 0.8 (1.2–3.5) NS
.29) 0.16 0.01 (0.13–0.19) 0.001
0.09) 0.07 0.01 (0.04–0.09) 0.001
7) 1.6 0.23 (1.1–2.4) 0.001
2) 5.1 1.2 (4.1–9.7) 0.001
) 36.1 6.2 (22–50) NS
ects and white athletes. †More significant compared with black control subjects but not with white
of variance; BP  blood pressure; BSA  body surface area; E  early diastolic mitral valve peak
thickness; LA diam.  left atrial diameter; LVIDd  maximal left ventricular cavity dimension in
le.
Figure 1 Bar Chart Showing the Distribution of Left
Ventricular Wall Thickness in Black and White Athletes
A substantial minority (3%) of black athletes exhibited a left
ventricular wall thickness 15 mm, compared with none of the white athletes.ontro
and B
s (n 
14–35
–120)
7–14)
42–66
–47)
13–48
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June 10, 2008:2256–62 LV Remodeling in Black AthletesLeft ventricular hypertrophy was predominantly seen in
lack athletes participating in boxing, basketball, soccer, and
printing, most of whom were of West African ancestry. In
ontrast, relatively few white athletes of similar age and
SA, participating in the same sporting disciplines, exhib-
ted LVH (Fig. 2). Black athletes participating in sprinting,
oxing, and basketball exhibited a significantly greater
agnitude of LVH compared with black athletes in other
porting disciplines (analysis of variance: p 0.01). None of
he long distance black runners, who were all East African,
xhibited LVH.
ardiac structure and function. The pattern of LVH in
lack and white athletes was homogeneous, with no athlete
howing 2 mm difference in LV wall thickness measure-
ents between contiguous segments. All athletes with LVH
lso exhibited an enlarged LV cavity size ranging between
5 and 66 mm and normal indexes of diastolic function on
ransmitral Doppler and TDI (Tables 1 and 2), and none
emographics and Echocardiographic Parameters of 9 Black Athle
Table 2 Demographics and Echocardiographic Parameters of 9
Athlete #
Age
(yrs)
BSA
(m2)
Ancestral
Origin
Sporting
Discipline
LVWd
(mm)
LV
(m
1 18 1.89 West African Soccer 15
2 18 1.90 West African Boxing 15
3 20 1.98 Afro-Caribbean Boxing 15
4 23 2.04 West African Sprinting 15
5 24 2.08 Afro-Caribbean Basketball 15
6 26 2.09 West African Basketball 15
7 19 2.15 West African Boxing 16
8 24 2.24 West African Basketball 16
9 26 2.32 Afro-Caribbean Rugby 16
bbreviations as in Table 1.
Figure 2 LVH in Relation to Sporting
Disciplines in Black and White Athletes
More black athletes exhibited left ventricular hypertrophy (LVH) compared with
white athletes in all 6 main sporting disciplines examined. Bas  basketball;
Box  boxing; LDR  long distance running; Rug  rugby; Soc  soccer; Spr
 sprinting; Ten  tennis.tisplayed systolic anterior motion of the mitral valve and
ssociated LV outflow obstruction.
CG in black athletes with LVH. Black athletes with
VH exhibited a higher prevalence of voltage criteria for
VH compared with white athletes with LVH (37 [68%]
s. 5 [40%]; p  0.001). Black athletes with LVH also
isplayed a higher prevalence of repolarization changes,
pecifically ST-segment elevation (46 [85%] vs. 7 [62%];
 0.001) and deep T-wave inversions (7 [12%] vs. none
0%]; p 0.0001) compared with white athletes with LVH.
eep T-wave inversions (0.2 mV) in black athletes
ere confined to leads V1 to V4 and present in 4 of the 9
thletes with substantial LVH 15 mm. Deep T-wave
nversions were not an ECG manifestation in white
thletes with LVH.
None of the athletes exhibited deep T-wave inversions in
he inferior or lateral leads, baseline ST-segment depres-
ion, left atrial enlargement, pathologic Q waves, left bundle
ranch block, or leftward axis.
eterminants of LVH (all athletes). A multivariate linear
odel assessing the relation between LV wall thickness and
everal demographic variables showed an independent associ-
tion between LV wall thickness and weight (  0.008 
.002; p 0.001; 95% confidence interval [CI] 0.003 to 0.013)
nd African/Afro-Caribbean ethnicity ( 0.21  0.03; p 
.001; 95% CI 0.14 to 0.28).
eliability of maximal LV wall thickness measurements
n athletes. The averaged coefficients of variance for in-
raobserver and interobserver reliability for maximal LV wall
hickness were 4.6% and 6.8%, respectively.
xercise stress testing and 48-h ECG. Athletes with
VH underwent exercise stress testing and achieved 85%
f the predicted target heart rate and adequate BP re-
ponses. None of the athletes exhibited ST-segment depres-
ion or arrhythmias during the exercise protocol. There were
o differences in the mean peak systolic BP between black
thletes and white athletes (189  18.4 mm Hg vs. 183 
5.8 mm Hg).
None of the athletes with LVH showed episodes of
onsustained ventricular tachycardia or supraventricular
ith LVH >15 mm
k Athletes With LVH >15 mm
LA
(mm)
E
(m/s)
A
(m/s) E/A
E=
(m/s) E/E=
Deep T-Wave
Inversion
37 0.9 0.5 1.8 0.18 5 0
37 0.95 0.3 3.1 0.2 4.8 V2–V4
39 1.1 0.4 2.8 0.23 4.8 V1–V3
40 0.89 0.25 3.6 0.19 4.7 0
40 1.2 0.5 2.4 0.22 5.5 0
39 1.4 0.3 4.6 0.25 5.6 V1–V4
41 0.96 0.4 2.4 0.2 4.8 V3–V4
42 0.9 0.3 3 0.19 4.7 0
47 1.2 0.3 4 0.25 4.8 0tes W
Blac
IDd
m)
56
57
57
60
60
62
57
65
64achyarrhythmias over a 24-h period.
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ardiac structure in highly-trained and nationally ranked
lack athletes has not been previously reported; therefore,
he physiologic range of LV wall thickness measurements in
his cohort is unknown. Sudden death from HCM in the
.S. is more common in black athletes compared with white
thletes (5), underscoring the need for developing upper
imits for LVH in black athletes to facilitate accurate
ifferentiation between physiologic LVH and HCM.
Compared with the Italian Olympian study of 738 white
ale athletes in 1991 (5), only 300 black male athletes were
tudied, because black athletes constitute just 20% to 25% of
he entire elite British athletic population. However, the
tudy revealed that almost one-fifth of black athletes exhib-
ted LVH compared with just 4% of white athletes. Fur-
hermore, a significant minority (3%) of black athletes (but
one of the white athletes) had substantial LVH (15
m), which could have been consistent with morphologi-
ally mild HCM. These results are striking compared with
he Italian Olympian athletes, in which only 0.08% of 738
en exhibited LVH 15 mm (1), indicating a racial
redilection to developing LVH in response to the increased
re- and after-load associated with intensive exercise. A
ombination of genetic (18), endocrine, and hemodynamic
actors (19) probably accounts for the increased LVH in
lack athletes. In the present study, basal and exercise-
elated BP responses in both groups of athletes did not differ
nd could not explain the increased magnitude of LVH in
lack athletes.
With the exception of sprinting, where black athletes
ominate, we investigated sporting disciplines in which
oth black and white athletes participate in large numbers
nd excel equally, revealing that more black athletes than
hite athletes exhibited LVH in almost every sporting
iscipline examined. Disciplines such as cycling and rowing,
hich are associated with substantial LVH in white ath-
etes, were not examined, because the lack of participation
nd, more importantly, failure to attain athletic excellence
y black athletes in these disciplines would not enable direct
omparisons.
ifferentiating physiologic LVH from HCM in black
thletes. The differentiation between physiologic LVH
nd HCM is crucial, because diagnostic errors have poten-
ially grave consequences. In this regard, conclusions derived
rom LV wall thickness measurements in white athletes
1,3,4) may have resulted in a diagnosis of HCM and
isqualification from competitive sport in 9 black athletes
3%) with LVH 15 mm. However, none of the 9 athletes
xhibited other morphologic features suggestive of HCM.
pecifically, none exhibited a nondilated LV cavity (4),
nlarged left atrium 50 mm (20), LV obstruction (21), or
vidence of impaired myocardial relaxation (14,22).
Indeed, all of the black athletes with LVH, including the
athletes with substantial LVH (Table 2), exhibited a large
V cavity (55 mm) compared with individuals with dCM. In our experience, LV cavity size in HCM is 50
m, even in affected individuals participating in regular
port against medical advice (23). An LV cavity55 mm in
CM is due to progressive myocardial fibrosis and is
ssociated with myocardial thinning, systolic dysfunction,
nd, importantly, reduced New York Heart Association
unctional class (24).
All black athletes with LVH also exhibited enhanced LV
lling and normal left atrial pressures (E/E= 7) on TDI,
upporting physiologic adaptation rather than HCM. In
ontrast, TDI studies in HCM have convincingly identified
V filling abnormalities in gene-positive HCM individuals,
ven before the development of LVH (25).
Upright exercise testing and ambulatory ECG in athletes
ith LVH failed to identify abnormalities in BP responses
o exercise (18) or nonsustained ventricular tachycardia (26),
hich constitute the broad spectrum of the HCM pheno-
ype in a substantial number of affected individuals (27).
CG in black athletes with LVH. In contrast to white
thletes, 7 black athletes (12%) with LVH, including 4 with
VH 15 mm, displayed deep T-wave inversions in leads
1 to V4, a recognized ECG manifestation in HCM and
rrhythmogenic right ventricular cardiomyopathy. In keep-
ng with the recommendations of the 36th Bethesda guide-
ines (28) and the European Society of Sports Cardiology
29), we were compelled to investigate all 7 black athletes
ith cardiac magnetic resonance imaging (outside of the
cope of the study) and failed to identify apical HCM,
arked hypertrophy of the anterolateral wall (30), myocar-
ial fibrosis, or characteristic right ventricular morphology-
ssociated arrhythmogenic right ventricular cardiomyopathy
n any athlete (31). In the absence of obvious pathology, we
uspect these electrical anomalies (deep T-wave inversions
n leads V1 to V4) in black athletes probably represent a
ormal spectrum of ECG changes in response to physical
raining (32), but we concede that long-term longitudinal
tudies are required to assess the precise significance of such
epolarization changes in all athletes.
iagnostic algorithm for differentiating physiologic
VH from HCM in black athletes with substantial
VH. The present study provides foundations for develop-
ng a pragmatic clinical algorithm for differentiating phys-
ologic LVH from HCM in black male athletes age 16
ears using readily available and independently interpretable
ardiac investigations. As previously shown in white athletes
4), black athletes with physiologic LVH exhibit enlarged
V cavity 55 mm, a left atrial diameter 50 mm, and
ormal indexes of diastolic function on pulse Doppler and
DI in contrast to most individuals with HCM. Only black
thletes age 16 years exhibited LVH (4); therefore, age is
lso pertinent when differentiating physiologic adaptation
rom HCM.
Although genetic testing is the most specific method of
iagnosing HCM, the diverse genetic heterogeneity of
H
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June 10, 2008:2256–62 LV Remodeling in Black AthletesCM and incomplete knowledge of all causal mutations do
ot currently allow a timely genetic diagnosis (6 months)
n athletes striving for honors or competing for team
election. Unfortunately, failure to identify an abnormality
fter screening for known mutations for HCM cannot
urrently be regarded as exclusion of disease.
Based on standard objective assessment we could not
ssign an LVH 15 mm in black athletes to be represen-
ative of inheritance of HCM-causing gene mutations in
ny athlete. Figures relating to the actual prevalence of
CM in the general population are also relevant in this
egard, because the prevalence is only 0.2% (33) and
ertainly less in the athletic population (34); therefore, it is
mprobable on statistical grounds that 3% of all black
thletes in the present study had HCM.
The substantial LVH identified in some athletes could
ave been attributed to the possible use of performance-
nhancing drugs (35), but we were constrained on profes-
ional, ethical, and financial grounds from probing into drug
buse. However, all athletes had competed at the national
evel and were subject to random antidoping investigations.
onclusions
lack athletes constitute a large proportion of athletes
articipating at the national level in the U.S. and United
ingdom. A substantial minority of black athletes also
xhibit LVH 15 mm. We propose that in the absence of
ardiac symptoms or a family history of HCM, an LV wall
hickness 15 mm in black athletes may represent physio-
ogic LVH when the LV cavity is enlarged and diastolic
ndexes are normal. Recommendations based on our obser-
ations should permit a more accurate evaluation of black
thletes with LVH.
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